COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 417: Articles 4161-4170  | Next

An App-Based Ecological Momentary Assessment of Undergraduate Mental Health During the COVID-19 pandemic in Canada (Smart Healthy Campus Version 2.0): Longitudinal Study
Brogly, C., Lizotte, D. J., Mitchell, M., Speechley, M., MacDougall, A., Huner, E., Anderson, K. K., Bauer, M. A.
10.1101/2023.03.22.23287598 — Posted: 2023-03-28
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Galanis, P. A., Katsiroumpa, A., Vraka, I., Chrysagi, V., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Gallos, P., Kaitelidou, D.
10.1101/2023.03.27.23287816 — Posted: 2023-03-28
SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling
Dies, B., de Lucas-Rius, A., Mendoza, L., Garcia, T., Fernandez, R., Suarez, J. M., Milhano, F., Corrales, F., Redondo, N., Pedrucci, F., Zaldivar, S., Jimenez, M. A., Montoya, M., Garrido, J. J.
10.1101/2023.03.27.534381 — Posted: 2023-03-27
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme, K. F. A., Hoste, L., Declercq, J., De Leeuw, E., Maes, B., Martens, L., Colman, R., Browaeys, R., Bosteels, C., Verwaerde, S., Vermeulen, N., Lameire, S., Debeuf, N., Deckers, J., Stordeur, P., Guilliams, M., Schetters, S., Haerynck, F., Tavernier, S. J., Lambrecht, B. N.
10.1101/2023.03.25.23287712 — Posted: 2023-03-27
Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: the four-way decomposition analysis
Djuric, O., Larosa, E., Cassinadri, M., Cilloni, S., Bisaccia, E., Pepe, D., Bonvicini, L., Vicentini, M., Venturelli, F., Giorgi Rossi, P., Pezzotti, P., Mateo Urdiales, A., Bedeschi, E.
10.1101/2023.03.27.23287795 — Posted: 2023-03-27
Facility-based and virtual cardiac rehabilitation in young patients with heart disease during the COVID-19 era
Aronoff, E. B., Chin, C., Opotowsky, A. R., Mays, W., Knecht, S. K., Goessling, J. E., Rice, M. C., Shertzer, J., Wittekind, S., Powell, A. W.
10.1101/2023.03.24.23287722 — Posted: 2023-03-27
Sequential viral introductions and spread of BA.1 drove the Omicron wave across Pakistani provinces
Bukhari, S. A. R. S., Ashraf, J., Kanji, A., Rehman, Y., Trovao, N. S., Thielen, P. M., Yameen, M., Kanwar, S., Khan, W., Kabir, F., Nisar, M. I., Merritt, B., Hasan, R., Spiro, D., Rasmussen, Z., Bashir, U., Hasan, Z.
10.1101/2023.03.25.23287718 — Posted: 2023-03-27
Trends in STI testing, diagnoses, and use of online chlamydia self-sampling services among young people during the first year of the COVID-19 pandemic in England
Sonubi, T., Sheik-Mohamud, D., Ratna, N., Bell, J., Talebi, A., Mercer, C. H., Sinka, K., Migchelsen, S. J., Folkard, K., Mohammed, H.
10.1101/2023.03.22.23287571 — Posted: 2023-03-27
Lower vaccination coverage against COVID-19 in school-aged children is associated with low socioeconomic status in the Metropolitan Area of Santiago, Chile.
Guerrero-Araya, E., Ravello, C. R., Rosemblatt, M., Perez-Acle, T.
10.1101/2023.03.27.23287800 — Posted: 2023-03-27
AI-Designed, Mutation-Resistant Broad Neutralizing Antibodies Against Multiple SARS-CoV-2 Strains
Kang, Y., Jiao, Y., Jin, K., Pan, L.
10.1101/2023.03.25.534209 — Posted: 2023-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).